Hetero Labs and Optimus Pharma had approached the drug regulatory authority last month seeking waivers from conducting local trials. However, their proposal was turned down.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/Z67K3bz
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Nod for Paxlovid's Indian generic version to take longer
https://ift.tt/FXHnecp
No comments:
Post a Comment